Discontinued — last reported Q1 '26
Merck & Co. Livestock — Sales decreased by 46.1% to $1.06B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 42.4%, from $1.85B to $1.06B. Over 4 years (FY 2021 to FY 2025), Livestock — Sales shows an upward trend with a 4.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growing demand for animal health solutions or successful market expansion in the agricultural sector, while a decrease may signal competitive pressure or cyclical downturns in livestock production.
This metric represents the total revenue generated from the sale of animal health products specifically designed for liv...
Comparable to animal health segment revenues reported by diversified pharmaceutical or specialized veterinary health companies, often evaluated against global livestock production trends.
mrk_segment_livestock_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.64B | $1.73B | $1.58B | $1.66B | $1.65B | $1.66B | $1.63B | $1.70B | $1.62B | $1.75B | $1.61B | $1.70B | $1.67B | $1.77B | $1.78B | $1.85B | $1.92B | $2.05B | $1.98B | $1.06B |
| QoQ Change | — | +5.4% | -8.5% | +5.2% | -0.7% | +0.4% | -1.9% | +4.5% | -4.9% | +8.2% | -7.8% | +5.4% | -1.5% | +5.9% | +0.3% | +3.9% | +4.0% | +6.5% | -3.5% | -46.1% |
| YoY Change | — | — | — | — | +0.7% | -4.1% | +2.8% | +2.1% | -2.2% | +5.4% | -0.9% | +0.0% | +3.7% | +1.4% | +10.3% | +8.8% | +14.8% | +15.5% | +11.1% | -42.4% |